NL-OMON48481招募中2 期
Treatment of locally advanced VULvar CArcinoma in a Neoadjuvant setting with Carboplatin and Paclitaxel chemotherapy - VULCANize
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 51 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Woman >= 18 years
- •Signed and written informed consent.
- •Histologically confirmed squamous cell vulvar carcinoma
- •World Health Organization performance status of 0-2
- •Adequate hematological function
- •Adequate hepatic function
- •Adequate renal function
- •Negative pregnancy test for woman of childbearing potential
- •measurable disease by physical examination
- •TNM stage T2, any N, M0
排除标准
- •Vulvar cancer other than squamous cell carcinoma at biopsy
- •Previous radiotherapy of the vulva, groins or pelvis
- •Patients with metastasis limited to the pelvic lymph nodes, who can be
- •primarily operated with curative intent
- •Other diagnosis of malignancy or evidence of other malignancy for 5 years
- •before screening for this study
研究者
相似试验
进行中（未招募）
1 期
Treatment of locally advanced VULvar CArcinoma in a Neoadjuvant setting with Carboplatin and Paclitaxel chemotherapyEUCTR2019-003104-12-NLKI-AV51
招募中
2 期
Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)Locally Advanced, Squamous Cell Carcinoma of the VulvaNCT04192253The Netherlands Cancer Institute51
进行中（未招募）
1 期
Treatment of metastatic vulvar carcinoma in a neoadjuvant setting with Carboplatin and Paclitaxel chemotherapyEUCTR2019-000851-15-NLKI-AV12
尚未招募
2 期
Treatment of metastatic vulvar carcinoma in a neoadjuvant setting with Carboplatin and Paclitaxel chemotherapyvulva carcinoma10038594NL-OMON49490Antoni van Leeuwenhoek Ziekenhuis12
尚未招募
Unknown
A single center study to assess the safety and efficacy of escalated dose radiotherapy in locally advanced carcinoma rectumCTRI/2023/10/059088Chittaranjan National Cancer Institute (CNCI)